Skip to main content
. Author manuscript; available in PMC: 2011 Jun 8.
Published in final edited form as: Science. 2010 Nov 5;330(6005):831–835. doi: 10.1126/science.1191175

Table 1.

In vitro and bacterial cell–based assays for β-glucuronidase activity and inhibitor efficacy. kcat, catalytic rate; Km, Michaelis constant; N/A, not applicable. N.E., not effective. Errors represent standard deviation, where N = 3.

E. coli β-glucuronidase in vitro
E. coli cell–based
IC50 (nM) kcat/Km (s−1 μM−1) Ki (nM) EC50 (nM)
No inhibitor N/A 0.134 ± 0.0123 N/A N/A
Glucaro-δ-lactam 26400 ± 483 N/A 7750 ± 475 N.E.
Inhibitor 1 283 ± 26.1 0.0987 ± 0.00621 164 ± 13.0 17.7 ± 7.42
Inhibitor 2 369 ± 2.51 0.119 ± 0.00473 208 ± 25.4 28.3 ± 2.11
Inhibitor 3 586 ± 31.1 0.136 ± 0.00633 684 ± 81.6 233.2 ± 2.99
Inhibitor 4 1060 ± 3.54 0.122 ± 0.0205 1380 ± 166 1322.8 ± 1.15
HHS Vulnerability Disclosure